Provide your input and feedback to the pan-Canadian Advisory Panel on a Framework for a Prescription Drug List by end of business day on February 25, 2022.
MedAccessBC will be working with its coalition members to develop a submission. If you are interested in helping or have important thoughts, insights, contributions, or assistance to provide, please contact alow@medaccessbc.org. All patient organizations are encouraged to provide input to ensure that Canadians have fair and equitable access to medicines they need which extend life and improve quality of life.
CADTH has convened a time-limited, multidisciplinary advisory panel (the panel) to provide recommendations on a framework for developing a potential pan-Canadian prescription drug list or formulary. On behalf of the panel, CADTH invites stakeholders to provide input on a proposed framework for this potential pan-Canadian formulary. An accompanying discussion paper has been prepared to provide background information about the panel’s work. The panel was established to carry out the following:
- develop principles and a framework that could guide the development of a potential pan-Canadian formulary
- create a proposed sample list of commonly prescribed drugs and select related products as a test case based on a subset of the therapeutic areas that could be included on a potential pan-Canadian formulary
- establish criteria and a transparent process that could expand the proposed sample list to other therapeutic areas, and guide how new products could be added to the list and how a proposed list could be maintained over time
See: The pan-Canadian Advisory Panel on a Framework for a Prescription Drug List | CADTH (https://www.cadth.ca/pan-canadian-advisory-panel-framework-prescription-drug-list)
See: The pan-Canadian Advisory Panel on a Framework for a Prescription Drug List | CADTH (https://www.cadth.ca/pan-canadian-advisory-panel-framework-prescription-drug-list)